The global parenteral nutrition solutions market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The large volume parenteral (LVP) segment is expected to account for the largest share of the market in terms of revenue, followed by small volume parenteral (SVP). The basic infusion segment accounted for the largest share of the market in terms of revenue and is expected to continue its dominance over other segments during the forecast period. North America accounted for a major share in terms of revenue and is expected to continue its dominance over other regions during the forecast period.
Some Of The Growth Factors Of This Market:
- The global Parenteral Nutrition Solutions market is driven by the increasing prevalence of chronic diseases, rising geriatric population, and growing awareness about the benefits of parenteral nutrition solutions.
- The North American region dominates the global Parenteral Nutrition Solutions market due to high prevalence of chronic diseases and high healthcare expenditure in this region.
- Asia Pacific is expected to be the fastest-growing regional segment in terms of value over the forecast period.
- Increasing number of hospitals adopting parenteral nutrition solutions.
Industry Growth Insights published a new data on “Parenteral Nutrition Solutions Market”. The research report is titled “Parenteral Nutrition Solutions Market research by Types (Large Volume Parenteral (LVP), Small Volume Parenteral (SVP), ), By Applications (Basic Infusion, Therapeutic Infusion, Nutritious Infusion, ), By Players/Companies Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, CR Double-Crane, Pisa, Huaren, Patheon, Aspen Holdings, Beximco Pharma, Cook Pharmica, Albert David, PSI Ltd, Ozon Pharmaceuticals, BAG Healthcare, BML Parenteral Drugs, ”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Parenteral Nutrition Solutions Market Research Report
By Type
Large Volume Parenteral (LVP), Small Volume Parenteral (SVP),
By Application
Basic Infusion, Therapeutic Infusion, Nutritious Infusion,
By Companies
Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, CR Double-Crane, Pisa, Huaren, Patheon, Aspen Holdings, Beximco Pharma, Cook Pharmica, Albert David, PSI Ltd, Ozon Pharmaceuticals, BAG Healthcare, BML Parenteral Drugs,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Parenteral Nutrition Solutions Market Report Segments:
The global Parenteral Nutrition Solutions market is segmented on the basis of:
Types
Large Volume Parenteral (LVP), Small Volume Parenteral (SVP),
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Basic Infusion, Therapeutic Infusion, Nutritious Infusion,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter International Inc.
- Kelun Pharma
- B. Braun
- Fresenius
- Teva Pharmaceutical Industries
- Pfizer (Hospira)
- Ostuka Pharmaceutical
- CR Double-Crane
- Pisa
- Huaren
- Patheon
- Aspen Holdings
- Beximco Pharma
- Cook Pharmica
- Albert David
- PSI Ltd
- Ozon Pharmaceuticals
- BAG Healthcare
- BML Parenteral Drugs
Highlights of The Parenteral Nutrition Solutions Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Large Volume Parenteral (LVP)
- Small Volume Parenteral (SVP)
- By Application:
- Basic Infusion
- Therapeutic Infusion
- Nutritious Infusion
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Parenteral Nutrition Solutions Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Parenteral nutrition solutions are a type of intravenous (IV) solution that is given to patients who cannot eat or drink. These solutions are made up of water, electrolytes, and other nutrients that help the body to stay hydrated and nourished.
Some of the major players in the parenteral nutrition solutions market are Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, CR Double-Crane, Pisa, Huaren, Patheon, Aspen Holdings, Beximco Pharma, Cook Pharmica, Albert David, PSI Ltd, Ozon Pharmaceuticals, BAG Healthcare, BML Parenteral Drugs.
The parenteral nutrition solutions market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Parenteral Nutrition Solutions Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Parenteral Nutrition Solutions Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Parenteral Nutrition Solutions Market - Supply Chain
4.5. Global Parenteral Nutrition Solutions Market Forecast
4.5.1. Parenteral Nutrition Solutions Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Parenteral Nutrition Solutions Market Size (000 Units) and Y-o-Y Growth
4.5.3. Parenteral Nutrition Solutions Market Absolute $ Opportunity
5. Global Parenteral Nutrition Solutions Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Parenteral Nutrition Solutions Market Size and Volume Forecast by Type
5.3.1. Large Volume Parenteral (LVP)
5.3.2. Small Volume Parenteral (SVP)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Parenteral Nutrition Solutions Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Parenteral Nutrition Solutions Market Size and Volume Forecast by Application
6.3.1. Basic Infusion
6.3.2. Therapeutic Infusion
6.3.3. Nutritious Infusion
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Parenteral Nutrition Solutions Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Parenteral Nutrition Solutions Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Parenteral Nutrition Solutions Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Parenteral Nutrition Solutions Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Parenteral Nutrition Solutions Demand Share Forecast, 2019-2026
9. North America Parenteral Nutrition Solutions Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Parenteral Nutrition Solutions Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Parenteral Nutrition Solutions Market Size and Volume Forecast by Application
9.4.1. Basic Infusion
9.4.2. Therapeutic Infusion
9.4.3. Nutritious Infusion
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Parenteral Nutrition Solutions Market Size and Volume Forecast by Type
9.7.1. Large Volume Parenteral (LVP)
9.7.2. Small Volume Parenteral (SVP)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Parenteral Nutrition Solutions Demand Share Forecast, 2019-2026
10. Latin America Parenteral Nutrition Solutions Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Parenteral Nutrition Solutions Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Parenteral Nutrition Solutions Market Size and Volume Forecast by Application
10.4.1. Basic Infusion
10.4.2. Therapeutic Infusion
10.4.3. Nutritious Infusion
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Parenteral Nutrition Solutions Market Size and Volume Forecast by Type
10.7.1. Large Volume Parenteral (LVP)
10.7.2. Small Volume Parenteral (SVP)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Parenteral Nutrition Solutions Demand Share Forecast, 2019-2026
11. Europe Parenteral Nutrition Solutions Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Parenteral Nutrition Solutions Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Parenteral Nutrition Solutions Market Size and Volume Forecast by Application
11.4.1. Basic Infusion
11.4.2. Therapeutic Infusion
11.4.3. Nutritious Infusion
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Parenteral Nutrition Solutions Market Size and Volume Forecast by Type
11.7.1. Large Volume Parenteral (LVP)
11.7.2. Small Volume Parenteral (SVP) 11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Parenteral Nutrition Solutions Demand Share, 2019-2026
12. Asia Pacific Parenteral Nutrition Solutions Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Parenteral Nutrition Solutions Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Parenteral Nutrition Solutions Market Size and Volume Forecast by Application
12.4.1. Basic Infusion
12.4.2. Therapeutic Infusion
12.4.3. Nutritious Infusion
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Parenteral Nutrition Solutions Market Size and Volume Forecast by Type
12.7.1. Large Volume Parenteral (LVP)
12.7.2. Small Volume Parenteral (SVP)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Parenteral Nutrition Solutions Demand Share, 2019-2026
13. Middle East & Africa Parenteral Nutrition Solutions Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Parenteral Nutrition Solutions Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Parenteral Nutrition Solutions Market Size and Volume Forecast by Application
13.4.1. Basic Infusion
13.4.2. Therapeutic Infusion
13.4.3. Nutritious Infusion
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Parenteral Nutrition Solutions Market Size and Volume Forecast by Type
13.7.1. Large Volume Parenteral (LVP)
13.7.2. Small Volume Parenteral (SVP)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Parenteral Nutrition Solutions Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Parenteral Nutrition Solutions Market: Market Share Analysis
14.2. Parenteral Nutrition Solutions Distributors and Customers
14.3. Parenteral Nutrition Solutions Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Baxter International Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Kelun Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. B. Braun
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Fresenius
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Teva Pharmaceutical Industries
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pfizer (Hospira)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ostuka Pharmaceutical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. CR Double-Crane
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Pisa
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Huaren
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Patheon
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Aspen Holdings
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Beximco Pharma
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Cook Pharmica
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Albert David
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. PSI Ltd
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Ozon Pharmaceuticals
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. BAG Healthcare
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. BML Parenteral Drugs
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20.
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook